Jump to page content
The field of "Translational Bioethics" explores ethical and regulatory issues in pre-clinical and clinical research as well as in big data research. In empirical studies translational bioethics analyses, among other things, how legal requirements or ethical recommendations (e.g. informed consent, risk-benefit-assessments, or patient engagement) are applied in research practice. On the basis of study results and in close cooperation with researchers, patient representatives and other relevant stakeholders, proposals are then developed on how these guidelines and recommendations can be implemented more effectively and efficiently in practice.

[Translate to englisch:] Teaser Reihe 1


    BRAVO examines the extent to which Germany's medical faculties consider and promote various aspects of quality of biomedical research.

    Further information
  • CEO-sys

    CEO-sys will build a Covid-19 evidence ecosystem to improve knowledge management and translation. It is part of the Forschungsnetzwerk Nationale Universitätsmedizin.

    Further information

    EMBARC examines to what extent previously approved animal testing applications have published their results and study methods.

    Further information

[Translate to englisch:] Teaser Reihe 2

  • HiGHmed

    HiGHmed involves the Work Package “Ethics and Stakeholder” which undertakes interdisciplinary research on ethical, policy and social issues on Medical Informatics topics.

    Further information

    PRECOPE (Preparedness + Response for Ethical Challenges in Human Subject Research during COVID-19 and similar PandEmics) addresses the application of existing ethical standards in pandemics.

    Further information

[Translate to englisch:] Teaser Reihe 3

[Translate to englisch:] Teaser Reihe 4

Prof. Dr. Dr. Daniel Strech

Head of research group | Deputy Director QUEST Center

CV | ORCIDTwitter

Contact information
Phone:+49 30 450 543 068